Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma

authors:

avatar Takashi Himoto 1 , * , avatar Kazutaka Kurokohchi 2 , avatar Seishiro Watanabe 3 , avatar Tsutomu Masaki 2

Department of Integrated Medicine, [email protected], Japan
Department of Gastroenterology and Neurology, School of Medicine, Kagawa University, Japan
Department of Internal Medicine, Kagawa Prefectural Central Hospital, Japan

how to cite: Himoto T, Kurokohchi K, Watanabe S, Masaki T. Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma. Hepat Mon. 2012;12(10):5945. doi: 10.5812/hepatmon.5945.

Abstract

Contexts:

Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed.

Evidence Acquisition:

At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments.

Results:

New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects.

Conclusions:

This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.

Full Text

Full text is available in PDF

© 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.